Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024

Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024

Human medicines European public assessment report (EPAR): Qutenza, capsaicin, Date of authorisation: 15/05/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Qutenza, capsaicin, Date of authorisation: 15/05/2009, Revision: 19, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022

Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness